【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2766次   下载 2464 本文二维码信息
码上扫一扫!
PEP-1介导的重组肝细胞核因子4α蛋白转导对肝癌细胞的抑制作用
邓龙飞1,丁晨虹2,谢渭芬2,张新1,2*
0
(1. 华东理工大学生物工程学院, 上海 200237;
2. 第二军医大学长征医院消化内科, 上海 200003
*通信作者)
摘要:
目的 利用细胞穿膜肽PEP-1介导重组肝细胞核因子4α(HNF4α)蛋白进入肝癌细胞,并明确外源融合蛋白P-HNF4α对肝癌细胞的作用。方法 构建表达质粒pET28a-P-HNF4α,优化原核表达体系的诱导条件,经大量表达、亲和层析纯化及浓缩、透析后获得纯度较高的带有细胞穿膜肽PEP-1的融合蛋白P-HNF4α;P-HNF4α转导人肝癌细胞,蛋白质印迹法检测其穿膜效率,核质分离和细胞免疫荧光检测P-HNF4α的亚细胞定位,Real-time PCR检测肝癌细胞基因表达,CCK-8法检测肝癌细胞增殖,细胞划痕实验及小室侵袭实验检测P-HNF4α对肝癌细胞转移能力的影响。结果 细胞穿膜肽PEP-1成功介导融合蛋白P-HNF4α进入Huh7细胞并定位于细胞核;P-HNF4α蛋白可促进Huh7细胞肝功能基因表达,抑制干细胞相关基因表达(P<0.05或0.01),并显著抑制肝癌细胞增殖(P<0.05)、迁移(P<0.001)和侵袭(P<0.05)能力。结论 P-HNF4α可诱导肝癌细胞向成熟肝细胞分化,降低肝癌细胞的恶性程度,是诱导分化治疗肝癌的潜在手段。
关键词:  肝细胞癌  肝细胞核因子4α  细胞穿膜肽  PEP-1
DOI:10.3724/SP.J.1008.2015.00929
投稿时间:2014-12-17修订日期:2015-07-31
基金项目:国家自然科学基金(81372675),国家科技重大专项(2013ZX10002007-007).
Inhibitory effect of PEP-1-mediated recombinant hepatocyte nuclear factor 4 alpha transduction on hepatocellular carcinoma cells
DENG Long-fei1,DING Chen-hong2,XIE Wei-fen2,ZHANG Xin1,2*
(1. School of Biotechnology, East China University of Science and Technology, Shanghai 200237, China;
2. Department of Gastroenterology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
*Corresponding author)
Abstract:
Objective To investigate cell penetrating peptide (PEP-1)-mediated transduction of recombinant hepatocyte nuclear factor 4 alpha (HNF4α) protein into hepatocellular carcinoma (HCC) cells, and to observe the effect of the fusion protein P-HNF4α on HCC cells. Methods The expression vector pET28a-P-HNF4α was constructed. The prokaryotic expression condition of fusion protein P-HNF4α was optimized. Recombinant P-HNF4α carrying cell penetrating peptide PEP-1 was obtained by abundant expression, purified by affinity chromatography, and was concentrated and dialyzed. P-HNF4α was transduced into HCC cells. The transduction efficiency was analyzed by Western blotting analysis. Sub-cellular localization of P-HNF4α was detected by Western blotting analysis with nuclear and cytoplasmic extracts and confirmed by immunofluorescence assay. Real-time RT-PCR was used to examine the gene expression of HCC cells. The proliferation of HCC cells was detected with CCK-8 kit. The migration and invasion of HCC cells were detected by wound-healing assay and trans-well invasion assay, respectively. Results P-HNF4α was efficiently transduced into Huh7 cells and located in the nucleus as mediated by PEP-1. P-HNF4α significantly up-regulated the expression of characteristic hepatocyte markers and down-regulated the "stemness" genes in Huh7 cells (P<0.05 or P<0.01). Moreover, the proliferation (P<0.05), migration (P<0.001) and invasion (P<0.05) of HCC cells were significantly suppressed by fusion protein P-HNF4α. Conclusion P-HNF4α can induce the differentiation of HCC cells to mature hepatocytes and reduce the malignancy phenotype of HCC cells, suggesting that PEP-1-mediated HNF4α protein transduction may be a potential strategy for HCC differentiation therapy.
Key words:  hepatocellular carcinoma  hepatocyte nuclear factor-4 alpha  cell penetrating peptide  PEP-1